DUBLIN, September 28, 2017 /PRNewswire/ -- The "Heart Valve Repair and Replacement Devices Market" report has been added to Research and Markets' offering.
The market for heart valve repair and replacement devices is anticipated to experience healthy growth during the forecast period (2016-21), increasing to an estimated $8.1bn by 2021.
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for heart valve repair and replacement devices.
Ad Statistics
Times Displayed: 50453
Times Visited: 1437 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Topics Covered Include:
An overview of heart valve repair and replacement devices, including percutaneous balloon valvuloplasty, heart valve surgery (repair and replacement), transcatheteraortic valve replacement (TAVR), and transcathetermitral valve regurgitation (TMVrep) products.
Global and country/region-specific market forecasts, including forecasts by product segment.
Competitive analyses by product segment.
Discussion of key drivers and limiters to the heart valve repair and replacement devices market.
Country and region-specific insights that are shaping device markets.
Report Highlights:
Heart valve repair and replacement devices are used in the treatment of heart valve disease, which gradually wear out the heart and can lead to the development of heart failure, blood clots, stroke, and sudden cardiac arrest.
Transcatheter heart valve repair and replacement device sales are expected to account for the largest share of total market sales.
Sales of transcatheterheart valve repair and replacement devices, specifically TAVR and TMVrep, are steadily supplanting sales of more invasive heart valve repair and replacement products as a result of clinical data supporting these products as safer alternatives.
The US market for heart valve repair and replacement devices accounted for approximately 50% of all sales, followed by the five major European markets (France, Germany, Italy, Spain, and the UK). The strongest growth in product sales is expected to occur in the Japanese market.
Key Topics Covered:
Executive Summary
1. Heart Valve Disorders Overview
1.1 Types of heart valve disorders
1.1.1 Valvular stenosis
1.1.2 Tricuspid valve/pulmonary valve stenosis
1.1.3 Valvular regurgitation
1.1.3.1 Aortic valve/mitral valve regurgitation
1.1.4 Valve prolapse
1.2 Conditions associated with heart valve disorders
1.2.1 Congenital defects
1.2.2 Acquired disorders
1.2.3 Calcific degeneration
1.2.4 Infective endocarditis
1.2.5 Rheumatic fever
1.2.6 Heart failure
